Where does Biogen Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biogen Inc. ranks #25,877 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biogen Inc. hold?

Biogen Inc. holds 10 US utility patents granted between 2015 and 2021, spanning 10 technology areas.

What is Biogen Inc.'s Innovation Score?

Biogen Inc. has an Innovation Score of 26.2 out of 100 (top 81% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Biogen Inc.'s patent grant rate increasing or decreasing?

Biogen Inc.'s recent grant velocity is -57% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biogen Inc.'s patents?

Biogen Inc.'s patents average 11.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biogen Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biogen Inc.

Q: What technology areas does Biogen Inc. focus on?

Biogen Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 8 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biogen ranks #25,877 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 10 technology areas.

#25,877
of 50,000 US assignees by volume: Top 81%
by Innovation Score (26.2/100): 11.2
avg claims per patent: -57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25877 · US Corporation #25,877 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,877/50,000
PHOTO-FINISH Big Elk Energy Systems
CPC-FOCUS A61P · 10 areas
INNOV-THIN 26.2/100
CLAIMS-PAR 11.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -57% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Big Elk Energy Systems, Llc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Biogen · this assignee

26
3D Lighting Innovati… · lowest

7

What this shows Biogen's Innovation Score is 26.2/100 (top 81% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Biogen's grants concentrate

Biogen Inc. is a focused PatentsView assignee: 10 CPC subclasses with 80% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2015. By volume, Biogen sits between Big Elk Energy Systems, Llc and Bitro Group, Inc..

Big Elk Energy Sy…

10
Biolink Systems

10
Biosystems Consul…

10
Biocept

10
Biomerica

10
Biotec Pharmacon…

10
Biotronik CRM Pat…

10
Bitro Group

10
Biogen ◀

10

What this shows Biogen holds 10 patents at rank #25,907, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biogen

By rank, the assignees closest to #25,907 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Biogen's primary technology class.

Biogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 Top 81% higher than 19% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biogen Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2016	3	30.0%
2018	1	10.0%
2019	2	20.0%
2020	1	10.0%
2021	2	20.0%

Which technologies does Biogen Inc. patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 8

C07K - PEPTIDES 8

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 8

Y10S - TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS 2

C02F - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE 2

C07D - HETEROCYCLIC COMPOUNDS 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#25,877

of 50,000 tracked assignees

Innovation Score

26.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.